SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED
UK SIC 2007 82990 in United Kingdom · GB. Public registry data, filed financials, business card, and annual valuation trend on one indexed company profile.
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED
Net asset reference trend
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED is shown here as a public net-asset reference from filed balance sheets. It is not an earnings-multiple valuation; owner or advisor data is needed for debt, asset quality, leases and marketability adjustments.
View the valuation
Create a free account to see this company's public annual range. Private precision requires owner status, accountant access, or permission shared by the owner.
View for freeFree account · no card required
This is a public asset-reference range, not an earnings-multiple valuation or a final transaction value. More accuracy requires owner or advisor context.
This range is anchored to filed net assets. Add debt, asset quality, leases, off-balance-sheet items and marketability context to turn it into a stronger private valuation.
About SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED is a UK SIC 2007 82990 based in United Kingdom, the United Kingdom. The company was founded in 1994, incorporated as a ltd.
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED is listed in Companies House under registry number 02950518. This profile consolidates Brønnøysund, Companies House Profile, KBO registry, KvK registry, NBB/CBSO annual accounts, official annual accounts, Staatsbladmonitor public filings, Titan Official Financials into one indexable company dossier.
Companies in this NACE 82.99 band file annual accounts with Companies House, which is the regulator-filed source used throughout this page.
An indicative valuation band is available for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED, indicative, given the source coverage available; the exact annual range stays behind the valuation chart until the visitor creates a free account. The chart below uses 2 historical valuation checkpoints to show the movement by fiscal year: a datapoint banks and acquirers explicitly ask for.
The most recent annual filing covers 2025 (period end 2025-08-31), sourced via Brønnøysund.
If you are researching SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED for acquisition, investment, or due-diligence purposes, the firmographics, multi-year filings, indicative valuation, and source provenance on this page draw from the same enrichment pipeline our internal valuation engine uses.
Registered details
- Registry
- GB 02950518
- Status
- active
- Founded
- 1994-07-14
- Legal form
- ltd
- NACE
- 82.99: UK SIC 2007 82990
- Region
- United Kingdom
Sources and public data
The public enrichment for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED combines, where available, Brønnøysund, Companies House Profile, KBO, KvK and Upswitch sector calibration. Raw payloads and operational error details are not public; this page only shows the safe summary.
- Brønnøysundskipped
- Companies House Profileok
- KBOskipped
- KvKskipped
- NBB/CBSOskipped
- NBB/CBSOskipped
- official filingsYears 2025, 2024
- Staatsbladskipped
- Titan Official Financialsskipped
Filed annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Aug 2025 | - | - | - | €10,000 | - |
| 202431 Aug 2024 | - | - | - | €10,000 | - |
Frequently asked questions about SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED
- What is the estimated business value of SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED?
An indicative valuation band is available for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED. The estimate uses a low confidence model built on publicly filed accounts and sector multiples. The exact public range is available with a free account; a precise valuation requires normalised owner or advisor data.
- When was SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED founded?
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED was founded in 1994 and is registered with Companies House, incorporated as a ltd.
- What sector does SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED operate in?
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED is registered under NACE 82.99: UK SIC 2007 82990. That places the business within the British cluster for this activity.
- Where is SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED based?
According to the company registry, SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED is based in United Kingdom, GB.
- When did SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED last file annual accounts?
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-08-31), publicly available via Companies House.
- Is SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED for sale?
There is no public listing for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED at this time. Owners can claim the company to start a private or public sale process; prospective acquirers can register interest from this page.
This page shows an automated, indicative valuation generated by Upswitch from publicly filed data (Companies House) and sector benchmarks. It is not a certified or statutory valuation and not financial, investment, tax or legal advice. Figures for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions
Are you connected to SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED?
The indicative valuation above is built from public filings and sector multiples. To turn it into a precise, defensible valuation and view the deal-readiness analysis, verify your role below. Free account, no card required.
I own this company
Verify ownership and connect your books to replace the indicative band with the precise upswitch_adaptive valuation. Get the sellability score, deal-readiness checklist, and the right time to list.
Claim as ownerI am the accountant
Prepare the file for sale: deal-readiness analysis, normalisation workspace, owner profile, and the listing flow. Track all your clients from one accountant dashboard.
Start analysis as advisorSector and geographic context
UK SIC 2007 82990
Compare UK SIC 2007 82990 businesses across Belgium and the Netherlands: sector multiples, deal dynamics, and valuation quirks.
Open sector profileOther companies like this
Public profiles for peers in the same industry and country. Click through to compare filings and indicative valuations.